Medical Devices Startups
6,448 companies tagged Medical Devices, with their investors and founders.
Axent Biosciences develops stem cell therapies to treat diseases like Parkinson's, using a proprietary cell cultivation platform to enable scalable and cost-effective manufacturing. The company was spun out of UC Berkeley research and aims to make stem cell therapies broadly accessible.
1 investor
Axial Orthopaedics is a medtech company in orthopedic healthcare, with leadership experienced in strategic exits.
1 investor
Axis Spine Tech develops a modular ALIF (anterior lumbar interbody fusion) spinal implant system that lets surgeons intra-operatively select implant height and lordotic angle to achieve and maintain spinal alignment. The system is designed for spine surgeons, with endplate-protection technology intended to improve fusion and clinical outcomes.
1 investor
Axitare is a Finnish health technology company that develops an automated, cup-based medication dispenser with alarm for elderly people living at home, serving home care organisations and wellbeing services counties. Its device dispenses pre-portioned medicines in a cup without requiring users to open packaging or press buttons, and it operates in Finland and Denmark.
1 investor
Axogen develops surgical technologies and solutions for peripheral nerve repair procedures across various anatomical locations. The company serves surgical specialists and healthcare providers seeking to establish nerve function restoration as a standard treatment approach.
1 investor
Axonics Modulation, now part of Boston Scientific, develops medical devices in the field of neuromodulation therapies for patients. The content presented is directed to healthcare professionals.
1 investor
Axora Medical develops minimally invasive hysteroscopy solutions for gynecologists to diagnose and treat intrauterine conditions such as polyps and fibroids in both office and operating room settings.
1 investor
Axxam develops AXXSense, a cell-based platform for assessing taste and olfactory properties of pharmaceutical compounds during drug development. The platform uses human bitter taste receptors and trigeminal assays to predict bitterness and off-tastes early in the pipeline, helping pharmaceutical companies optimize formulations and reduce late-stage reformulation risks.
1 investor
AZBio is a statewide industry association and advocate for Arizona's bioscience sector, connecting biotech, medtech, and healthcare organizations to support the state's life science ecosystem. The organization provides resources, leadership, and advocacy to establish Arizona as a top-ten life science state.
1 investor
Azevan Pharmaceuticals is a clinical-stage biopharmaceutical company developing orally bioavailable V1a receptor antagonists targeting vasopressin biology for neuropsychiatric, neurodegenerative, neurodevelopmental, and brain injury conditions. The company's lead candidate SRX246 has shown efficacy in reducing pathological aggression in Huntington's Disease and Intermittent Explosive Disorder.
1 investor
Azimuth Medical develops Air-Sequr, smart protective trousers embedded with sensors and an airbag system that automatically deploys upon fall detection to protect the hip. The wearable technology is designed for fall prevention and injury mitigation.
1 investor
Azkarra Therapeutics develops small molecule drugs targeting DNA damage repair and immune response pathways for cancer and inflammatory diseases. The company focuses on novel PARP inhibitors, PARG inhibitors, and OGG1 inhibitors as next-generation precision therapeutics.
1 investor
azulOptics develops eye-health screening technologies focused on prevention and early detection of eye disease. The company serves optometry providers and eye-care professionals with diagnostic instruments and related healthcare products.
1 investor
Azura Ophthalmics develops a new therapeutic class of ophthalmic keratolytics aimed at treating lid margin and ocular surface diseases and other underserved ophthalmic conditions. The company applies drug development expertise to address the core pathophysiology of these eye conditions.
1 investor
B-Secur provides ECG signal sensing and algorithm software for wearable and medical device manufacturers, supporting electrode design, regulatory compliance, and clinical validation from prototype through FDA submission.
1 investor
BabyMD operates a network of neighborhood pediatric clinics offering consultations, vaccinations, developmental assessments, and therapy services for children and families. The clinics operate 7 days a week in Bangalore, India, with a focus on compassionate, personalized care.
1 investor
Bainbridge Health provides software solutions for hospital pharmacy operations, including infusion safety analytics, IV formulation management, and drug library development. The company serves over 800 hospitals and life sciences organizations to reduce medication errors, drug waste, and improve pharmacy efficiency.
1 investor
Bako Diagnostics provides laboratory diagnostic services specialized in testing nail, skin, wound, soft tissue, and bone samples from the lower extremity for the podiatric medical community. The company offers proprietary PCR tests, resistance testing, staining procedures, and bacterial identification through insurance-backed in-network services.
1 investor
Band Connect develops a hybrid rehabilitation platform that combines in-person and remote physical therapy delivery to enhance clinician-patient relationships while improving patient compliance and outcomes. The platform serves health systems and rehabilitation providers delivering musculoskeletal care.
1 investor
BangBang Robotics develops mobility assistance robots and intelligent transportation solutions for users with lower limb mobility impairments. The company serves the disability and elderly care markets with a range of products including transfer chairs, walking assistance devices, and smart home robots.
1 investor
BCV Systems develops a mechatronic guidewire system using shape memory alloy actuators to optimize navigation during minimally invasive endovascular procedures for stroke treatment and other vascular interventions. The technology provides practitioners with direct access and control through tortuous blood vessels, compatible with existing catheter platforms and robotic systems.
1 investor
BASi supplies analytical instrumentation and scientific research services to pharmaceutical companies developing new drugs. The company aims to accelerate drug development through improved instrumentation and research capabilities.
1 investor
BayOmics is a proteomics company founded in January 2022 that develops proprietary technologies and tools for protein research to advance disease diagnosis and drug discovery. The company offers research services, reagent kits, instrument platforms, and integrated solutions for applications including tissue microenvironment analysis, biomarker development, and drug target identification.
1 investor
BBI Solutions provides reagents and biochemical products for in vitro diagnostics and life sciences teams, supporting assay development and diagnostic test manufacturing. The company serves IVD manufacturers and life sciences researchers with enzymes, gold colloids, and recombinant reagents.
1 investor





